Cargando…

Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway

Acquired resistance to cisplatin is the most common reason for the failure of cisplatin chemotherapy. Hederagenin, triterpenoids extracted from ivy leaves, exhibits antitumor activity in various types of cancer. However, the therapeutic potential of hederagenin in head and neck cancer (HNC) has rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Hye, Baek, Seungho, Shin, Daiha, Lee, Jaewang, Roh, Jong-Lyel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804377/ https://www.ncbi.nlm.nih.gov/pubmed/29456786 http://dx.doi.org/10.1155/2017/5498908

Ejemplares similares

Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis
por: Lee, Jaewang, et al.
Publicado: (2020)

RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems
por: Shin, Daiha, et al.
Publicado: (2017)

Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
por: Roh, Jong-Lyel, et al.
Publicado: (2016)

Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer
por: Shin, Daiha, et al.
Publicado: (2020)

Accelerated oral wound healing using a pre-vascularized mucosal cell sheet
por: Lee, Jaewang, et al.
Publicado: (2017)

Retraction Note: Accelerated oral wound healing using a pre-vascularized mucosal cell sheet
por: Lee, Jaewang, et al.
Publicado: (2021)

Development of an in vitro cell-sheet cancer model for chemotherapeutic screening
por: Lee, Jaewang, et al.
Publicado: (2018)

Use of a pre-vascularised oral mucosal cell sheet for promoting cutaneous burn wound healing
por: Lee, Jaewang, et al.
Publicado: (2018)

Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2022)

Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2020)

Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
por: Roh, Jong-Lyel, et al.
Publicado: (2014)

SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
por: Lee, Jaewang, et al.
Publicado: (2022)

Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
por: Lee, Jaewang, et al.
Publicado: (2023)

Targeting Iron-Sulfur Clusters in Cancer: Opportunities and Challenges for Ferroptosis-Based Therapy
por: Lee, Jaewang, et al.
Publicado: (2023)

Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells
por: Wang, Kun, et al.
Publicado: (2020)

PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
por: You, Ji Hyeon, et al.
Publicado: (2021)

Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats
por: Lu, Su-Hong, et al.
Publicado: (2015)

Hederagenin Supplementation Alleviates the Pro-Inflammatory and Apoptotic Response to Alcohol in Rats
por: Kim, Gyeong-Ji, et al.
Publicado: (2017)

Evaluation of the anti-Toxoplasma gondii Activity of Hederagenin in vitro and in vivo
por: Zhang, Run-Hui, et al.
Publicado: (2021)

The protective effect of hederagenin on renal fibrosis by targeting muscarinic acetylcholine receptor
por: Yang, Wei, et al.
Publicado: (2022)

Risk Factors and Survival Outcomes for Patients With Anastomotic Leakage After Surgery for Head and Neck Squamous Cell Carcinoma
por: Kim, Do-Youn, et al.
Publicado: (2014)

A hederagenin saponin isolated from Clematis ganpiniana induces apoptosis in breast cancer cells via the mitochondrial pathway
por: Cheng, Lin, et al.
Publicado: (2018)

Hederagenin Attenuates Cerebral Ischaemia/Reperfusion Injury by Regulating MLK3 Signalling
por: Yu, Hailong, et al.
Publicado: (2020)

Tolfenamic Acid Induces Apoptosis and Growth Inhibition in Head and Neck Cancer: Involvement of NAG-1 Expression
por: Kang, Sung Un, et al.
Publicado: (2012)

Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review
por: Zeng, Jia, et al.
Publicado: (2018)

Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study
por: Dai, Yuxiang, et al.
Publicado: (2022)

Proteomics identifies differentially expressed proteins in glioblastoma U87 cells treated with hederagenin
por: Zhang, Yesen, et al.
Publicado: (2023)

Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica
por: Chakroborty, Anand, et al.
Publicado: (2023)

Hederagenin from the leaves of ivy (Hedera helix L.) induces apoptosis in human LoVo colon cells through the mitochondrial pathway
por: Liu, Bao-Xin-Zi, et al.
Publicado: (2014)

Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective Study
por: Kang, Ho-Seob, et al.
Publicado: (2016)

Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
por: Bostan, Marinela, et al.
Publicado: (2021)

Use of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Rare Head and Neck Cancers
por: Roh, Jong-Lyel, et al.
Publicado: (2008)

TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling
por: Xu, Teng, et al.
Publicado: (2023)

The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer
por: Roh, J-L, et al.
Publicado: (2013)

Chondroradionecrosis of the Larynx: Diagnostic and Therapeutic Measures for Saving the Organ from Radiotherapy Sequelae
por: Roh, Jong-Lyel
Publicado: (2009)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Mdm2 and p53 Expression in Radiation-Induced Sarcomas of the Head and Neck: Comparison with De Novo Sarcomas
por: Song, Min Jeong, et al.
Publicado: (2014)

Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
por: Osman, Abdullah A., et al.
Publicado: (2023)

Design, Synthesis, and Cytotoxic Analysis of Novel Hederagenin–Pyrazine Derivatives Based on Partial Least Squares Discriminant Analysis
por: Fang, Kang, et al.
Publicado: (2018)

Combined Squamous Cell Carcinoma and Follicular Carcinoma of the Thyroid
por: Son, Da Hye, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8g055v43nouatt7aeja36dgnnn